ScholarWorks@Gyeongsang National University: Lee, Gyeong Won

Detailed Information

Lee, Gyeong Won (이경원)

의과대학 (의학과)

Research Area

Tel
E-mail
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Prognosis:11||Cachexia:8||Lymphoma:8||Diffuse large B cell lymphoma:7||Diffuse large Bcell lymphoma:7||Sarcopenia:7||nonsmall cell lung cancer:6||Lazertinib:6||Survival:5||Small cell lung carcinoma:5||Nonsmall cell lung cancer:5||diffuse:4||Rituximab:4||Cisplatin:4||prognosis:4||Serum albumin:4||large Bcell:4||Overall survival:3||Platinum:3||Positron emission tomography:3||lymphoma:3||Multiple myeloma:3||NSCLC:3||Leukemia:3||Neutrophils:3||breast cancer:3||Lung cancer:3||S1:3||Nonsmallcell lung carcinoma:3||Lymphocytes:3||rituximab:3||Doxorubicin:3||Oxaliplatin:3||Marginal zone:3||PMLRARα:3||Gemcitabine:3||Toxicity:2||Biomarker:2||platelettolymphocyte ratio:2||Clinical trial:2||cancer:2||multiple myeloma:2||progressionfree survival:2||EGFR:2||Deep vein thrombosis:2||Bcell:2||Lung neoplasm:2||chemotherapy:2||chronic:2||Epidemiology:2||Myelodysplastic syndrome:2||Immunotherapy:2||Carcinoma:2||reimbursement:2||Breast cancer:2||Sequencedependent:2||Insurance:2||Peripheral Tcell lymphoma:2||Treatment outcome:2||Germinal center:2||Hiccup:2||lymphocytic:2||lymphocyte:2||Cervix cancer:2||small cell lung carcinoma:2||inflammation:2||irinotecan:2||spirometry:2||Peroxiredoxin:2||Maintenance:2||survival:2||Chemotherapy:2||thrombocytopenia:2||Monocyte:2||Acute promyelocytic leukemia:2||Taxol:2||Dexamethasone:2||Quality of life:2||Large Bcell:2||Pulmonary thromboembolism:2||IPSS:2||apoptosis:2||ERCC1:2||Diffuse:2||nutrition assessment:2||overall survival:2||health:2||Isoform:2||Progressionfree survival:2||Endothelial Activation and Stress Index:1||Epidermal growth factor ointment:1||Epidermal growth factor receptor:1||Epidermal growth factor receptor (EGFR):1||Epidermal growth factor receptor mutation:1||EpsteinBarr viruspositive:1||Erlotinib:1||Factor Xa inhibitors:1||Fasciitis:1||Firstline treatment:1||GRP94:1||Glasgow Prognostic Score:1||Glucocorticoid:1||Glutamine:1||HER2 positive:1||HIF1 alpha:1||HLA:1||HLAB*40:489:1||Haplotype:1||Haplotypetagging SNP:1||Hemoglobins:1||Hepatic failure:1||Home care services:1||Hsp90 beta:1||Human mammaglobin:1||Hypomethylating agents:1||Hypomethylating therapy:1||Ibritumomab tiuxetan:1||Ibrutinib:1||Immune checkpoint inhibitors:1||Induction:1||Inflammatory markers:1||Interstitial lung disease:1||Interstitial pneumonitis:1||Intestines:1||Khorana score:1||Korea:1||Locally advanced:1||Lowerrisk:1||Lung Neoplasms:1||Lymphocyte:1||Lymphocyte count:1||MAPK:1||MDS:1||MGMT protein:1||Magnetic Resonance Imaging:1||Magnetic resonance imaging:1||Malnutrition:1||Marginal zone lymphoma:1||Mature Tcell neoplasm:1||Metastatic breast cancer:1||Methylprednisolone:1||Microarray:1||Mixedphenotype acute leukemia:1||Monomorphic epitheliotropic intestinal Tcell lymphoma:1||Monosomal karyotype:1||Mucosaassociated lymphoid tissues:1||Multicenter:1||Multiple:1||Myeloid:1||Naloxone:1||Needs assessment:1||Neoadjuvant chemotherapy:1||Neoplasm staging:1||Nephrotoxicity:1||Neutrophil to lymphocyte ratio:1||Neutrophiltolymphocyte ratio:1||Nilotinib:1||Nomogram:1||Nomograms:1||Notch4:1||Nutrition assessment:1||O6methylguanine DNA methyltransferase:1||Oct3:1||Old age:1||Open label:1||Opioidrelated disorders:1||Orbital and Ocular Adnexal MALT lymphomas:1||Osimertinib:1||Outcomes:1||Oxycodone:1||P2Y(2)receptor:1||PD1 inhibitor:1||PLR:1||Pancreatic cancer:1||Pancytopenia:1||Pegfilgrastim:1||Pembrolizumab:1||Pemetrexed:1||Philadelphianegative:1||Plasmacytoma:1||Predictive factor:1||Prescription drug misuse:1||Primary myelofibrosis:1||Prognostic factor:1||Prognostic factors:1||Prognostic scores:1||Programmed cell death ligand1:1||Prophylaxis:1||Pulmonary:1||Pulmonary disease:1||Pyoderma Gangrenosum:1||RCHOP:1||RCVP:1||Radioimmunotherapy:1||Refractory:1||Relapse:1||Respiratory hospitalization:1||Rivaroxaban:1||Rural population:1||S100A8:1||S100A9:1||SCLC:1||Safety:1||Salvage:1||Salvage therapy:1||Sarcoma:1||Single nucleotide polymorphism:1||Skin:1||Small cell lung cancer:1||Smallcell lung carcinoma:1||Splenic volume:1||Splenomegaly:1||Statin:1||Stem cell transplantation, autologous:1||Stem cell transplantation, tandem autologous:1||Stereotactic body radiation therapy:1||Stomach neoplasms:1||Subtype:1||Surgery:1||Symptom assessment:1||Syncope:1||Tcell:1||T790M:1||TIGIT antibody:1||TKI:1||Target therapy:1||Thalidomide:1||Thrombosis:1||Trastuzumab biosimilar:1||Treatment:1||Treatment pattern:1||Tumor necrosis:1||Tumor staging:1||Tyrosine kinase inhibitor:1||Tyrosine kinase inhibitor (TKI):1||Urbanization:1||Usefulness:1||Vandetanib:1||Venetoclax:1||Venous thrombosis:1||Vincristine:1||Vinorelbine:1||XRCC1:1||Yttrium90:1||acute lymphoblastic leukemia:1||adenosine:1||alveolar soft part sarcoma:1||arterial stiffness:1||autologous stem cell transplantation:1||background potassium channel:1||biliary neoplasm:1||breast neoplasms:1||calcium:1||case reports:1||caspase3:1||cell migration assays:1||cell therapy:1||chronic obstructive:1||cisplatin:1||computed tomography:1||creatinine:1||ctDNA:1||cytogenetics:1||cytosine arabinoside:1||depression:1||diffuse large Bcell lymphoma:1||docetaxel:1||drug resistance:1||drug toxicity:1||elderly:1||endothelium:1||erlotinib:1||exosome:1||extracellular vesicles:1||gastric cancer:1||gender:1||genomic instability:1||head and neck cancer:1||hematopoietic stem cell transplant:1||hematopoietic stem cell transplantation:1||hypermethylation:1||immune cell fraction:1||immune checkpoint inhibitor:1||immunoglobulin D:1||interstitial pneumonitis:1||intestinal fistula:1||intrathecal chemotherapy:1||intussusception:1||lactate dehydrogenase:1||lazertinib:1||lung:1||magnetic resonance imaging:1||male:1||mantle cell lymphoma:1||marginal zone lymphoma:1||mediastinum:1||metastatic NSCLC:1||methotrexate:1||microRNAs:1||mortality:1||muscle:1||myeloid sarcoma:1||myoferlin protein:1||nasal cavities:1||nephrotic syndrome:1||neutropenia:1||neutrophil:1||neutrophiltolymphocyte ratio:1||new allele:1||nextgeneration sequencing:1||nonsmall cell lung:1||nonsmallcell lung cancer:1||oxaliplatin:1||paranasal sinus:1||paraneoplastic syndromes:1||paroxetine:1||parvovirus B19:1||platinum:1||prednisone:1||protein kinase C:1||pulmonary vessel:1||pulse wave velocity:1||pure red cell aplasia:1||radiation pneumonitis:1||radiotherapy:1||radiotherapyresistant breast cancer cells:1||reactive oxygen species:1||recurrence:1||refractory:1||relapse:1||response rate:1||review:1||rituximabCHOP:1||safety:1||salvage therapy:1||sarcopenia:1||serum albumin:1||small cell lung cancer:1||smallcell lung:1||smoking:1||squamous cell carcinoma:1||surgical resection:1||tanshinone I:1||thrombocytosis:1||thymoma:1||tissue array analysis:1||treatment outcome:1||upper gastrointestinal bleeding:1||vascular endothelial growth factor receptor2:1||급성전골수구성백혈병:1||독소루비신:1||사회적 지원:1||이형:1||자궁암:1||재가암 서비스:1||증상 평가:1||탁솔:1||투여순서:1||#946:1||페록시레독신:1||&:1||catenin:1||3rd generation EGFR TKI:1||4:1||5fluorouracil:1||A2AR:1||ABCG2:1||Acute kidney injury:1||Acute lymphoblastic leukemia:1||Acute myeloid leukemia:1||Advanced biliary tract adenocarcinoma:1||Advanced gastric cancer:1||Advanced pancreatic carcinoma:1||Advanced stage:1||Adverse event:1||Akt:1||Albumin to globulin ratio:1||Allogeneic hematopoietic cell transplantation:1||Amphisome:1||Ann Arbor stage:1||AntiXa assay:1||Anticoagulants:1||Antithymocyte globulin:1||Aplastic anemia:1||Asia:1||Asian:1||Asian subpopulation:1||Autologous stem cell transplantation:1||Azacitidine:1||B cell lymphoma:1||BCell:1||Bcell lymphoma:1||BEAM regimen:1||BM blast:1||Bax:1||Bcl2:1||Bendamustine:1||Biomarkers:1||Body weight:1||Bone marrow involvement:1||Bortezomib:1||Brain tumor:1||Bullous pyoderma gangrenosum:1||Busulfan:1||CD44:1||CNS:1||CSC markers:1||Cancer:1||Cancerassociated thrombosis:1||Carboplatin:1||Case report:1||Central nervous system:1||Chromosomal abnormalities:1||Chromosomal abnormality:1||Chronic lymphocytic leukemia:1||Chronic myeloid leukemia:1||Chronic obstructive pulmonary disease:1||Chronic phase:1||Cisplatin uptake:1||Clinical outcomes:1||Clinical study:1||Combination:1||Combination chemotherapy:1||Complex karyotype:1||Computed tomography:1||Concurrent chemoradiotherapy:1||Constipation:1||Controlling nutritional status:1||Corticosteroids:1||Cyclophosphamide:1||Cyclosporine:1||Cytotoxic Tlymphocyteeassociated antigen4:1||Daunorubicin:1||Decitabine:1||Diffuse large Bcell:1||Diffuse large cell lymphomas:1||Disseminated intravascular coagulation:1||Docetaxel:1||Drug therapy:1||Drugrelated side effects and adverse reactions:1||Durvalumab:1||EGFR T790Mpositive nonsmall cell lung cancer (NSCLC):1||EGFR mutation:1||EGFRTKI:1||EGFRmutated NSCLC:1||ERCC2:1||Elderly:1||Emphysema:1||

STATISTICS: Total View :5,587,143; Today View :7,322

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0533

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE